Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study and Preliminary Application Study on Noninvasive Iris Optical Coherence Tomography Angiography (OCTA)

NCT03631108 is registered in ClinicalTrials.gov with Shanghai Eye Disease Prevention and Treatment Center as lead sponsor.

NCT NCT03631108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03631108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study and Preliminary Application Study on Noninvasive Iris Optical Coherence Tomography Angiography (OCTA)
Lead sponsor
Shanghai Eye Disease Prevention and Treatment Center
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2018
Completion date
June 30, 2019
Enrollment
4,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

conjunctivitis, diabetic retinopathy, glaucoma, myopia, retinal detachment, retinal neovascularization, unspecified, uveitis